Number one recommended probiotic
Pro Research Analysisby 
Searched over 200M research papers
Number One Recommended Probiotic: A Comprehensive Review
Introduction to Probiotics
Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host. They are widely used for various gastrointestinal conditions, including antibiotic-associated diarrhea (AAD) and acute gastroenteritis (AGE). However, the efficacy of probiotics is highly strain-specific and disease-specific, making the choice of the right probiotic crucial for effective treatment and prevention.
Probiotics for Antibiotic-Associated Diarrhea (AAD)
Lactobacillus rhamnosus GG and Saccharomyces boulardii
For the prevention of antibiotic-associated diarrhea in children, the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) recommends the use of Lactobacillus rhamnosus GG and Saccharomyces boulardii. These recommendations are based on a systematic review of randomized controlled trials (RCTs) and are supported by moderate quality of evidence (QoE) with strong recommendations1. Both strains have shown efficacy in reducing the incidence of AAD, particularly in children with risk factors such as prolonged antibiotic use, hospitalization, and previous episodes of AAD1.
Probiotics for Acute Gastroenteritis (AGE)
Lactobacillus rhamnosus GG and Saccharomyces boulardii
In the management of acute gastroenteritis in children, Lactobacillus rhamnosus GG and Saccharomyces boulardii are also recommended. Despite the low quality of evidence, these probiotics have received strong recommendations due to their consistent performance in multiple RCTs2. They are suggested as adjuncts to rehydration therapy to help reduce the duration and severity of diarrhea in children2.
Evidence-Based Selection of Probiotics
Strain-Specific Efficacy
The selection of an appropriate probiotic is complex and should be based on the specific strain's efficacy for the targeted condition. A comprehensive review of 249 trials identified Saccharomyces boulardii I-745 and a three-strain mixture (Lactobacillus acidophilus CL1285, L. casei Lbc80r, L. rhamnosus CLR2) as having strong evidence for the prevention of AAD3. Additionally, Lactobacillus casei DN114001 has also shown strong efficacy in preventing AAD3.
Practical Considerations
When choosing a probiotic, it is essential to consider factors such as the specific strain, the targeted disease, the formulation, the dose, and the product's quality control and shelf-life. The efficacy of probiotics is not universal; it varies significantly depending on these factors3.
Conclusion
In summary, Lactobacillus rhamnosus GG and Saccharomyces boulardii are the most recommended probiotics for preventing antibiotic-associated diarrhea and managing acute gastroenteritis in children. Their efficacy is supported by multiple RCTs and systematic reviews, making them reliable choices for these conditions. However, the selection of a probiotic should always be tailored to the specific needs of the patient, considering the strain-specific and disease-specific efficacy.
Sources and full results
Most relevant research papers on this topic